Focal Segmental Glomerulosclerosis Treatment Market opportunities are expanding through the use of calcineurin inhibitors and other immunosuppressive therapies. These treatment options are considered in selected patients who do not respond adequately to initial treatment approaches, encouraging continued demand for specialized kidney disease medications.
The focal segmental glomerulosclerosis...